- Athens 2019
- Paris 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
Session Title: Femtolaser Cataract Surgery
Session Date/Time: Tuesday 08/10/2013 | 14:00-16:15
Paper Time: 15:02
Venue: Auditorium (First Floor)
First Author: : K.Meades AUSTRALIA
Co Author(s): : A. Siu
To determine the safety and efficacy of two different femtosecond laser cataract platforms, The Technolas TPV Victus and the Alcon LenSX.
60 patients were carefully assessed and selected to have cataract surgery. They were randomized to have the initial part of their surgery including incisions, capsulorhexis and lens fragmentation by either Platform 1 (TPV Victus) or Platform 2 (LenSX). Intraoperative Phaco time and power was recorded and uncorrected distance and near vision as well as any complications/difficulties were reported.
At the 3 months post operative visit, both groups demonstrated on average an improvement in uncorrected distance vision to 6/7.5. There was no difference in rates of complications between the two platforms
Both femtosecond laser cataract platforms resulted in patients with effective distance and/or near vision. Both Platforms also reduced phaco time and power by a comparable amount.
Please wait while information is loading.